IMA Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2K Buy
+121
New +$16.4K ﹤0.01% 637
2013
Q3
Sell
-24,600
Closed -$855K 175
2013
Q2
$855K Buy
+24,600
New +$864K 0.46% 74

Other funds holding XBI

IMA Advisory Services's XBI Position: Q2 2026 in Review

IMA Advisory Services opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 121 shares worth $19.2K. The stake represents ﹤0.01% of the portfolio and ranks #637 among its holdings. This is a return to the name: IMA Advisory Services previously reported a position in XBI as recently as Q2 2013.

IMA Advisory Services first reported a position in XBI in Q2 2013 and has held it in 2 quarters since. The position peaked at $855K in Q2 2013. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • IMA Advisory Services held 121 shares of State Street SPDR S&P Biotech ETF worth $19.2K as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new IMA Advisory Services position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of IMA Advisory Services's portfolio in Q2 2026, its #637 holding.
  • IMA Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 2 quarters since.
  • IMA Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $855K in Q2 2013.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.